Reports a novel GLUD1 mutation causing HI/HA syndrome in twins who developed seizures and cognitive impairment despite early treatment.
Answers are grounded in this paper and cite their sources.
Seizures and cognitive impairment may occur despite early treatment with this novel GLUD1 mutation; leaves open genotype-specific risks in HI/HA syndrome.
Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare autosomal dominant disease characterized by recurrent hypoglycemia and persistent mild elevation of plasma ammonia. HI/HA syndrome is one of the more common forms of congenital hyperinsulinism (CHI), caused by activating mutations within the GLUD1 gene that encodes the mitochondrial enzyme glutamate dehydrogenase (GDH). We report here on monozygotic twin girls presented with fasting- and protein-induced hypoglycemia and mild persistent hyperammonemia. Genetic analysis revealed that both girls were heterozygous for a novel missense mutation within exon 11 [c.1499A>T, p.(R443W)] of the GLUD1 gene. Despite early treatment with diazoxide and a low protein diet, they both developed non-hypoglycemic seizures in early childhood followed by cognitive impairment. In addition to their clinical course, a review of the literature on HI/HA syndrome is provided.
No takes yet. Share an insight, caveat, or question.
Ninković et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: